Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Zelensky names spy chief to head presidential office after corruption row - 2I'm a woman who's into weightlifting. Was I man enough for the creatine-packed 'Man Cereal'?
- 310 Energizing Vocations in the Innovation Business
- 4The most effective method to Really Adjust Hypothesis and Practice in Your Brain science Studies
- 5The Best Web-based Courses for Expertise Improvement
- Artemis II's moonbound toilet is working again to astronauts' relief after overnight fix
- Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- The most effective method to Go Down Abundance through Ages with Disc Rates
- Science is best communicated through identity and culture – how researchers are ensuring STEM serves their communities
- Best Exciting ride: Which One Rushes You the Most?
- Unwind: Four Extraordinary Spa Resorts On the planet
- How many ships have been attacked in the Gulf since start of Iran war?
- Compassion and Association: Building Significant Connections
- The secret appeal of Harlan Coben’s messy, addictive TV thrillers
